Food allergy, dermatologic diseases, and anaphylaxis
A pilot study of the usefulness and safety of a ready-to-use atopy patch test (Diallertest) versus a comparator (Finn Chamber) during cow's milk allergy in children

https://doi.org/10.1016/j.jaci.2005.08.033Get rights and content

Background

Patch testing is used in the diagnosis of food allergy, especially during delayed manifestations.

Objective

A ready-to-use atopy patch test (APT), the Diallertest, was compared with another APT device, the Finn Chamber, in pediatric cow's milk allergy.

Methods

This prospective study involved 49 children (34.3 ± 17 [mean ± SD] months of age), with cow's milk allergy manifested by atopic dermatitis (10.2%), digestive manifestations (40.8%), or both (49%). All children underwent both APT techniques, with a reading 72 hours after application, followed by a milk elimination diet for 4 to 6 weeks and open cow's milk challenge.

Results

A positive result was seen in 22 (44.8%) versus 13 (26.5%) patients with the ready-to-use and the comparator APTs, respectively. No side effects were recorded. Both techniques were concordant in 67.3% of patients. Of the total 41 open cow's milk challenges, 60.9% had positive results, with 8 patients lost to follow-up. The performances of the ready-to-use and comparator APTs were as follows: sensitivity, 76% (95% CI, 59.2% to 92.7%) versus 44% (95% CI, 24.5% to 63.4%; P = .02); specificity, 93.8% (95% CI, 81.9% to 100%) versus 93.8% (95% CI, 81.9% to 100%); positive predictive value, 95% (95% CI, 85.4% to 100%; 1 false-positive result) versus 91.7% (95% CI, 76% to 100%; 1 false-positive result); negative predictive value, 71.4% (95% CI, 52% to 90.7%; 6 false-negative results) versus 51.7% (95% CI, 33.5% to 69.8%; 14 false-negative results); and test accuracy, 82.9% (95% CI, 71.3% to 94.5%) versus 63.4% (95% CI, 48.6% to 78.1%; P = .05).

Conclusion

The ready-to-use APT exhibited a good sensitivity and specificity, with no side effects.

Section snippets

Patients

A prospective study was carried out between November 2003 and September 2004 in a population of 49 children (mean ± SD age, 34.3 ± 7 months; range, 5-78 months), 18 girls and 31 boys, enrolled after referral to an outpatient clinic for food allergy. Children exhibited at least one symptom of allergy, the main symptoms being atopic dermatitis (n = 5, 10.2%), digestive manifestations (eg, loose stools, colic, vomiting, gastroesophageal reflux, and failure to thrive; n = 20, 40.8%), and combined

Results

Among the 49 enrolled children, 5 (10.2%) exhibited positive specific CMP IgE results, and 1 (2%) had a positive SPT result. Results of the ready-to-use APT and the comparator were positive, respectively, in 22 (44.8%) and 17 (34.6%) patients (not significant) at 48 hours and 22 (44.8%) and 13 (26.5%) patients (not significant) at 72 hours. Both techniques appeared concordant in 32 (65.3%) patients at 48 hours and 33 (67.3%) patients at 72 hours.

Open challenges were carried out in 41 children,

Discussion

Our study shows that in the population of patients with CMA tested, with mostly delayed-onset reactions, the ready-to-use APT exhibited a significantly higher sensitivity (76% vs 44%) and test accuracy (82.9% vs 63.4%) than the comparator, whereas both techniques exhibited high specificity and positive predictive value and were devoid of any side effects.

Several authors underlined the usefulness of the APT in the diagnosis of food allergy in children with atopic dermatitis. In 183 patients with

References (30)

Cited by (0)

Supported by a grant from the pharmaceutical firm DBV-Technologies (Boulogne-Billancourt, France).

View full text